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ABSTRACT
Objective: Many forms of contraception are available
on prescription only for example, the oral contraceptive
pill (OCP) and long-acting reversible contraceptives
(LARCs). In this analysis we aim to identify key
determinants of prescription contraceptive use.
Design: Cross-sectional population survey. Data on
sociodemographic indices, concerns about the OCP
and perceived barriers to access were collected.
Setting: Data set constructed from a representative
population-based telephone survey of community
dwelling adults in the Republic of Ireland (RoI)
Participants: 1515 women aged between 18 and
45 years
Main outcome measure: Self-reported user of the
OCP or LARCs (intrauterine contraception,
contraceptive injections or subdermal contraceptive
implants) in the previous 12 months.
Results: For at least some of the previous year, 35%
had used the OCP and 14% had used LARCs, while
3% had used two or more of these methods. OCP
users were significantly younger, more likely to be
unmarried and had higher income than non-users.
Overall, 68% agreed with the statement ‘that taking a
break from long-term use of the contraceptive pill is a
good idea’ and 37% agreed with the statement that
‘the OCP has dangerous side effects’ and this was the
strongest predictor variable of non-use of the OCP.
Intrauterine contraception users were significantly
older, more likely to be married and had lower income
than non-users. Injections or subdermal contraceptive
implant users were significantly younger, less likely to
be married, had lower income and were less likely to
agree that taking a break from long-term use of the pill
is a good idea than non-users.
Conclusions: Prescription contraceptive use is
sociodemographically patterned, with LARCs in
particular being associated with lower incomes in the
RoI. Concerns about the safety of the OCP remain
prevalent and are important and modifiable
determinants of contraceptive-related behaviour.
INTRODUCTION
Many of the most effective and widely used
methods of contraception usually require a
prescription from a physician.1 Data from
the United Nations indicates that in more
economically developed regions, the oral
contraceptive pill (OCP), which is one such
method, is second only to male condom use
(18.4%) with an estimated international
prevalence rate of 17.7% in women who are
in a stable relationship.1 OCP use has
remained constant or has increased over the
past 10 years in many countries, including
Republic of Ireland (RoI) and the UK.2 3
The user-dependent nature of the OCP
means that the failure rate of the OCP is sub-
stantially greater than long-acting reversible
contraception (LARCs) methods for
example, intrauterine contraception and sub-
dermal contraceptive implants.4 However, it
is important to note that these methods are
not suitable for all women.5 There is also evi-
dence that negative attitudes and misconcep-
tions about speciﬁc types of LARC may be
pervasive6 7 including among healthcare pro-
viders;8 9 therefore, use of these methods
remains much lower than the OCP in many
countries.1
Strengths and limitations of this study
▪ This is the first study to provide a detailed popu-
lation level multivariable analysis of a range of
psychosocial determinants of prescription
contraceptive use, including concerns about the
safety of the oral contraceptive pill, in a represen-
tative sample of over 1500 women in the
Republic of Ireland.
▪ The study data were self-reported in a telephone
interview and may be subject to recall and social
desirability biases; however this is a widely used
method to collect data on sexual health from
large samples, and has established reliability and
validity.
▪ The identification of both modifiable and non-
modifiable determinants of prescription contra-
ceptive use can inform targeted interventions to
improve sexual and reproductive health.
Molloy GJ, et al. BMJ Open 2015;5:e007794. doi:10.1136/bmjopen-2015-007794 1
Open Access Research
group.bmj.com on October 15, 2015 - Published by http://bmjopen.bmj.com/Downloaded from 
Previous studies have shown that certain types of pre-
scription contraception tend to be more widely used by
certain demographic groups. However, these studies are
somewhat dated, of variable methodological quality and
from a limited range of sociocultural contexts.10
Additionally, these studies have not examined the inde-
pendence of sociodemographic predictors in accounting
for prescription contraception use. Some of these pre-
dictors become more closely related over time. For
example, age and marital status have become more
strongly associated with each other due to the increasing
age at which people marry and the rapidly changing pat-
terns of relationship stability in some countries.11 12 It is
also possible that there may be age-dependent beliefs
about contraception, for example, the OCP, which could
determine its use. This may be due to the high proﬁle
reporting of health risks associated with earlier versions
of the OCP to which older contraceptive users may have
been exposed and the improved safety of more recent
versions of the OCP.5 In the context of RoI, there is also
evidence that older contraceptive users may not have
received information on contraception as part of their
formal sex education.2 Analyses examining how beliefs
about the OCP vary by age are necessary in order to elu-
cidate under what conditions a range of factors explain
patterns of OCP use.
Beliefs about the safety of medical treatments are of
particular interest as these variables are potentially modi-
ﬁable determinants of uptake and adherence to pre-
scription contraception. There is a signiﬁcant body of
research focusing on the ‘Necessity-Concerns frame-
work’ of treatment adherence over the past 15 years.13 14
This approach emphasises the individual’s judgement of
personal need for medication or other forms of treat-
ment (necessity beliefs) and concerns about the poten-
tial adverse consequences of taking it for example, side
effects and long-term use. Although much of this litera-
ture focuses on chronic illness, more recent work has
identiﬁed similar associations between these treatment
beliefs and adherence to the OCP, particularly concerns
about the OCP.15 This latter study was in a small sample
of students (N=130) in the UK, therefore the external
validity of these ﬁndings is limited. In the present study,
we examine whether a range of sociodemographic vari-
ables, including concerns about the OCP and barriers to
access can account for prescription contraception use in
a representative sample of women between the ages of
18 and 45 in the general population in RoI. Speciﬁcally,
we examine OCP use and two types of LARC use,
namely intrauterine contraception and contraceptive
injections or subdermal contraceptive implants.
Although some studies have combined these into one
LARC user category,16 it is likely that the characteristics
of users vary for these methods given the previous
trends to avoid intrauterine contraception in nulliparous
women.17 18 Therefore, we assess intrauterine contracep-
tion use and contraceptive injections or subdermal
contraceptive implants use separately in our analysis.
Although these represent three distinct prescription
contraception methods, the latter two methods are com-
bined into one category in this study measure, due to
the low frequency of use of contraceptive injections and
subdermal contraceptive implants.
METHOD
Study design
Data were drawn from women who participated in the
Irish Contraception and Crisis Pregnancy Study 2010
(ICCP-2010).2 This was a nationally representative cross-
sectional survey of men and women between the ages of
18 and 45 who were living in RoI (N=3002; women
n=1515). The study was designed to describe attitudes,
knowledge and behaviours relating to sexual health and,
in particular, contraception and crisis pregnancy. Crisis
pregnancy in this context was deﬁned as “a pregnancy
that represents a personal crisis or an emotional trauma
in either of the following circumstances: (a) a pregnancy
that began as a crisis, even if the crisis was subsequently
resolved or (b) a pregnancy that develops into a crisis
before the birth due to a change in circumstances.”2
Setting and sample
This population-based telephone survey was conducted
in 2010. The random digit dialling of both landline and
mobile phones and the quota sampling technique that
was used to ensure a representative sample of the general
population within this age band are described in detail in
the main report and a separate publication.2 19 The
overall response rate to the survey was 69%.
Recruitment and consent
A standardised introduction to the study was used to
describe who was carrying out the survey, its conﬁdential
nature and how the telephone numbers had been ran-
domly selected. Following conﬁrmation that the
respondent was over 18 years of age and verbal agree-
ment to participate, the telephone interview began.
Questionnaire survey
The telephone-administered questionnaire collected
information on the participant’s sociodemographic data,
living arrangements, children, sex education, knowledge
and attitudes about contraception, contraceptive use
over the past year, sources of contraception and contra-
ceptive services, sexually transmitted infections, most
recent sexual partnership, experience of pregnancy and
knowledge of crisis pregnancy services, including abor-
tion. The full questionnaire and data set are available on
request from the Irish Social Science Data Archive. For
the present study, we highlight 10 variables in our main
analyses; these psychosocial variables were selected
based on previous literature and variables that capture
aspects of an individual’s motivation, capability and
opportunity to use prescription contraception, as
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deﬁned by the behaviour change wheel approach for
identifying factors for behaviour change interventions.20
Sociodemographic data
In addition to age in years, data were gathered on
marital and relationship status (married, separated,
divorced, widowed and never married), education
(primary or incomplete secondary only, complete sec-
ondary and third level) and whether respondents were
in receipt of general medical services (GMS). Such
entitlement is based on an assessment of individual’s
income and is therefore a reliable indicator of socio-
economic status; individuals with GMS have lower
incomes. In 2010, approximately 40% of the population
in RoI had GMS eligibility. At the time of this survey
patients with such eligibility receive all medications,
including contraceptives, free of charge; non-GMS
patients pay for all prescriptions up to a monthly limit of
approximately €90.
Prescription contraception use in the past year
In order to assess prescription contraception use,
respondents were asked ‘Which of these methods of
contraception or precautions to avoid pregnancy have
you and any partner (s) used together in the last year?’
The ﬁrst contraceptive mentioned on this list was ‘The
contraceptive pill’. The ﬁfth contraceptive method men-
tioned on the list was ‘Coil, intrauterine device or intra-
uterine system (Mirena)’. The eleventh method
mentioned was ‘Injections (Depo Provera) or Implanted
contraceptive capsules’ (Implanon). If respondents used
these in the past year, they were scored as 1 and if not,
they were scored as 0. It is important to note that this
would not necessarily refer to continuous use of these
methods. Participants were also asked which methods of
contraception or precautions to avoid pregnancy had
they ever heard of as part of this section.
Concerns about the OCP
Two items assessed concerns about the contraceptive
pill. These were, ‘The contraceptive pill has dangerous
side-effects’ and ‘Taking a break from the long-term use
of the contraceptive pill is a good idea’. These were
scored on a ﬁve-point scale from 1 Strongly Agree to 5
Strongly Disagree. Higher scores related to lower con-
cerns. There was a small to moderate positive correlation
between these two items (r=0.15, p<0.01), which indi-
cates that they can be treated as distinct but related
aspects of concerns about the OCP. A ‘Don’t know’
response that was not part of the ﬁve-point scale was
used by approximately 3% of the participants; therefore,
the two concern variables were dichotomised into
‘Agree’ versus ‘Other’ to preserve cases in the analyses.
Those scoring Strongly Agree and Agree were classiﬁed
as ‘Agree’ and all other responses were classiﬁed as
‘Other’.
Barriers to access
Various barriers to accessing contraception were assessed
in ICCP-2010. These included the following items: Do
not know where to get contraception/services, cannot
access contraception/services in your locality, are embar-
rassed about accessing contraception/services, cannot
afford contraception/services. The responses to these
items were ‘Yes’ or ‘No’. As less than 1% of the overall
sample responded ‘Yes’ to the item ‘Do not know where
to get contraception/services,’ this variable was not
included in the analyses. Therefore, these four variables
are binary variables where participants were classiﬁed as
Yes or No. Participants were also asked ‘How difﬁcult do
you ﬁnd it to get contraception?’ Responses were pro-
vided on a four-point scale from 1 very difﬁcult to 4 not
at all difﬁcult.
Data analyses
Descriptive statistics were calculated for the main study
variables in order to characterise the sample.
Independent t tests and χ2 tests for independence were
used to compare groups on continuous and categorical
data respectively. Logistic regression analyses were used
to test multivariable models. The ﬁnal complete multi-
variable model allowed the statistical independence of
the predictive variables to be established. Logistic regres-
sion provides ORs and 95% CIs for each predictor of
prescription contraception use, which calculates esti-
mates of effect sizes for the study predictors. As there
were 536 OCP users (35%) and 152 intrauterine contra-
ception users (10%) in this sample (n=1515), there were
sufﬁcient numbers of events per variable to use our mul-
tivariable logistic regression with 10 predictors.21 As
there were only 67 women using injections or subdermal
contraceptive implants (4%) this analysis could provide
less reliable estimates with 10 predictors. Moderation
analyses were carried out using the moderation script
for SPSS developed by Hayes and Matthes.22 Moderation
analyses were used to assess whether there were age-
dependent associations between beliefs about the OCP
and OCP use. This tested whether the strength of the
association between beliefs about the OCP and OCP use
varies for different age groups. All analyses were
weighted to ensure that the results are representative of
the population. Full details of the weighting parameters
used are provided in the ICCP-2010 report.2
RESULTS
Sample
An outline of the sample characteristics grouped by pre-
scription contraception users and non-users of that
method is provided in table 1. Forty-four women (3%)
had used two or more of the OCP, intrauterine contra-
ception, contraceptive injections or subdermal contra-
ceptive implants in the previous year, therefore the totals
do not equal 1515 participants in table 1. The three
most widely used methods of contraception were
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condoms (39%), the OCP (35%) and the intrauterine
contraception (10%). The ‘non-users of LARCs’ column
in table 1 refers to participants who neither used intra-
uterine contraception use nor subdermal contraceptive
implants as a method of contraception in the previous
year. Full details of the study sample are provided else-
where.2 Eighty-three per cent had heard of the OCP,
76% had heard of intrauterine devices/systems and 72%
had heard of injections or subdermal contraceptive
implants. Only 5% of women had not used any method
of contraception in the previous year. OCP users, com-
pared with non-OCP users, were signiﬁcantly younger,
were less likely to be married, less likely to be in receipt
of GMS, less likely to believe that the pill has dangerous
side effects, less likely to believe that taking a break from
the long-term use of the contraceptive pill is a good
idea, more likely to report difﬁculty in getting contra-
ception, more likely to report that they could not access
contraception/services in their locality and more likely
to say they could not afford contraception/services.
Intrauterine contraception users were signiﬁcantly older,
more likely to be married, less likely to have third level
education and more likely to be in receipt of GMS.
Injections or subdermal contraceptive implants users
were more likely to be signiﬁcantly younger, more likely
to be unmarried, more likely to be in receipt of GMS
and less likely to believe that taking a break from the
long-term use of the contraceptive pill is a good idea. In
the total sample (n=1515), 37% agreed with the state-
ment that the OCP had dangerous side effects and 68%
agreed that taking a break from long-term use of the
contraceptive pill was a good idea. The proportion of
participants in all groups who reported barriers to access
was relatively low that is, ≤5%.
In the multivariable analysis presented in table 2, all
study variables were included regardless of univariate
associations in order to assess the statistical independ-
ence of these determinants. In this table, ORs less than
1 are associated with non-use of the method; for
example, being married and having general medical ser-
vices were associated with non-use of the OCP as shown
in table 2. The multivariable model shows that younger
age, being unmarried, not being in receipt of GMS and
not believing that the OCP has dangerous side effects
emerged as signiﬁcant independent predictors of OCP
use. The strongest predictor was not agreeing with the
statement that ‘The contraceptive pill has dangerous
side effects’. This overall pattern of ﬁndings did not
change when the continuous measures of education and
concerns about the OCP were included in place of the
dichotomised variables. In table 2 intrauterine contra-
ception use and subdermal contraceptive implants use
are compared with non-use of these methods. Older
age, being married and being in receipt of GMS were
signiﬁcant predictors of intrauterine contraception use,
while younger age, being in receipt of GMS and not
agreeing that taking a break from the long-term use of
the contraceptive pill is a good idea were signiﬁcant
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predictors of injections or subdermal contraceptive
implants use. Being in receipt of GMS was the strongest
predictor of both LARCs methods. The multivariate
models accounted for a moderate amount of variability
in prescription contraception use as indicated by the
Nagelkerke R2 value.
Respondents who agreed that ‘The contraceptive pill
has dangerous side effects’ were signiﬁcantly older
(M=32.26, SD=7.83 years vs M=31.42, SD=7.41 years, t=
−2.06, p=0.04), as were respondents who agreed that
‘Taking a break from the long-term use of the contra-
ceptive pill is a good idea (M=32.61, SD=7.44 years vs
M=29.87, SD=7.53, t=−6.60, p<0.01). In moderation ana-
lyses, there was no signiﬁcant interaction between age
and believing that the OCP had dangerous side-effects
in predicting OCP use. However, there was a signiﬁcant
interaction between age and believing that taking a
break from the long-term use of the contraceptive pill
was a good idea (interaction term β=−0.05, p<0.01).
These age-dependent associations are provided in
table 3 below. This table compares the strength of this
association, that is, β values, at 1 SD above and below the
mean value of the moderator variable that is, age.
In older women, that is, those 1 SD above the mean age
of 31.85 years agreeing with this statement was strongly
predictive of pill non-use, whereas this was not the case
among younger women that is, those 1 SD below the
mean age. This decomposition of the interaction into
these three groups is recommended by statistical texts
describing this analytical method.22
DISCUSSION
The analysis provides a detailed description of the
characteristics of prescription contraception users in
Table 2 Multivariable logistic regression predicting prescription contraception use (1=Yes, 0=No) among study participants
(n=1515*)
OCP
Intrauterine
contraception
Injections or
subdermal
contraceptive
implant
Predictor variable OR 95% CI OR 95% CI OR 95% CI
Age in years (continuous) 0.92† 0.91 to 0.94 1.10† 1.06 to 1.13 0.92† 0.88 to 0.97
Unmarried (reference) 1.00 1.00 1.00
Married 0.67† 0.51 to 0.89 2.48† 1.62 to 3.80 1.09 0.56 to 2.13
Education at third level—no (reference) 1.00 1.00 1.00
Education at third level—yes 0.83 0.65 to 1.07 0.74 0.49 to 1.12 0.74 0.41 to 1.32
General medical services—no (reference) 1.00 1.00 1.00
General medical services—yes 0.62† 0.46 to 0.83 2.63† 1.76 to 3.91 2.31† 1.33 to 3.99
The OCP has dangerous side effects—other (reference) 1.00 1.00 1.00
The OCP has dangerous side effects—agree 0.52† 0.43 to 0.68 1.19 0.81 to 1.76 0.84 0.47 to 1.49
Taking a break from the long-term use of the OCP is a
good idea—other (Ref)
1.00 1.00 1.00
Taking a break from the long-term use of the OCP is a
good idea—agree
0.89 0.68 to 1.15 0.73 0.49 to 1.11 0.48† 0.28 to 0.81
How difficult do you find it to get contraception (continuous) 0.80 0.56 to 1.15 1.32 0.66 to 2.66 0.92 0.44 to 1.91
Cannot access contraception/services in your locality-no
(reference)
1.00 1.00 1.00
Cannot access contraception/services in your locality—yes 1.20 0.55 to 2.63 1.13 0.26 to 4.97 0.71 0.11 to 4.45
Are embarrassed about accessing contraception/services
—no (reference)
1.00 1.00 1.00
Are embarrassed about accessing contraception/services
—yes
0.69 0.32 to 1.52 1.48 0.39 to 5.68 0.16 0.01 to 2.13
Cannot afford contraception/services—no (reference) 1.00 1.00 1.00
Cannot afford contraception/services-—yes 0.88 0.40 to 1.92 2.31 0.63 to 8.44 0.99 0.00 to 0.00
Nagelkerke R2 for full model 0.17 0.18 0.11
*numbers vary due to missing values on one or more variables in analyses.
†<0.01; 1=Yes, 0=No; 1=Agree, 0=Other; 1=reference category for binary predictor variables.
OCP, oral contraceptive pill.
Table 3 Association between agreeing that ‘taking a
break from the oral contraceptive pill is a good idea’ and
OCP non-use across younger, average and older age
groups
Age in years β SE 95% CI β p Value
24.23 (−1 SD) 0.09 0.15 −0.20, 0.39 0.53
31.85 (mean) −0.26 0.12 −0.50, −0.02 0.03
39.46 (+ 1SD) −0.61 0.19 −0.98, −0.24 <0.01
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RoI. Lower income, as indexed by having GMS, was the
strongest predictor of both kinds of LARC use. These
results highlight that concerns about the OCP are
common and that these concerns are linked to prescrip-
tion contraception use, with the strongest predictor of
not using the OCP being the belief that ‘the contracep-
tive pill has dangerous side-effects’. The analysis also
shows that the association between concerns and OCP
use varied according to age, with the association being
particularly strong among older women. This might be
partly explained by exposure to historical reporting of
speciﬁc health risks associated with the OCP that have
since been shown to be unsupported.5 It is also likely
that the increased duration of exposure to the OCP that
older users will have may also partly account for this. In
the ICCP-2010 report2 there was evidence indicating
that contraception was a topic in the sex education of
70% of those between the ages of 18 and 25 years of age
in the survey, but only 34% of those between the ages of
36 and 45 years of age said that contraception was men-
tioned. This might also partly explain the greater con-
cerns about OCP reported by older women, as it is likely
that accurate information about contraception was
harder to access.
The independent links between prescription contra-
ception use and age, marital status and having GMS that
is, having lower income, are consistent with observations
seen in other countries.10 The prevalence and predictive
power of the two variables assessing concerns about the
OCP suggests that concerns may continue to have an
important role in contraceptive choice, as has been
observed in earlier studies in other contexts.23 The low
numbers of respondents reporting barriers to access
(≤5%) and the weak predictive power of ‘perceived difﬁ-
culty’ of ﬁnding contraception measure suggest that
access to contraception is no longer reported as a major
problem among adults in RoI and probably not an
important determinant of OCP use. However, it is
important to acknowledge that there may be barriers to
access in those under 18.24 The ﬁndings relating to sex
education in ICCP-20102 do indicate that contraception
is more likely to be part of the sex education of younger
cohorts. However, it is not universally covered according
to the data and there is a relatively recent history of
avoiding the topic in sex education,2 which may create
and reﬂect implicit social disapproval of contraception.
The predictive power of ‘concerns about the OCP’
and the potentially modiﬁable nature of these beliefs
suggest that reproductive health promotion needs to
place particular emphasis on shaping accurate beliefs
about the OCP and indeed LARCs’ methods to optimise
individual contraceptive choices. In addition to this, it is
clear that there are socioeconomic determinants of OCP
use in that the current results show that OCP use was
more common among those who did not have GMS that
is, those with higher income, and LARCs use was more
common among those who did have GMS that is, those
with lower incomes. Therefore, although few people
indicated that they could not afford contraceptive ser-
vices (<5%), it is likely that there are socioeconomic bar-
riers to contraception use. Recent intervention studies,
including natural experiments, suggest that removing
ﬁnancial and other access barriers can have a substantial
impact on uptake of contraceptives, particularly
LARCs.25 26
The OCP is currently a signiﬁcantly less expensive
option in the short term for those who do not have
GMS costing less than €20 per month. Therefore, it is
possible that LARCs methods, which may cost up to
€300 initially, are not ﬁnancially feasible for those with
incomes just above the threshold that would entitle
them to GMS. As a result, LARC use may predominate
in those with lowest incomes who do qualify for GMS
and those with higher incomes in RoI, where the initial
higher cost is not a barrier. It is also worth noting that
this socioeconomic difference seen within RoI reﬂects
socioeconomic differences between other countries in
respect of LARC use. For example, intrauterine contra-
ception is more commonly used and often freely avail-
able in less economically developed parts of the world,
for example, in Asia, there is a 27% prevalence among
women using contraception, whereas it is a relatively
expensive option in many more wealthier regions for
example, 6% prevalence in North America.18 The socio-
economic distribution of LARCs use in RoI is likely to
reﬂect the non-universal coverage of prescription contra-
ceptive costs for both the recipients and providers of
contraceptive services.
Contraception has been a controversial sociopolitical
topic in the RoI. Prescribing and having contraception
of any description was illegal in the RoI until 198027 and
emergency contraception was not available without pre-
scription until 2011.28 This can be largely explained by
the particular religious ethos that historically pervaded
healthcare and politics in RoI.29 This might also partly
explain the greater concerns about OCP reported by
older women in the present study. Given this cultural
backdrop, policy measures such as providing free contra-
ceptive services to all may be likely to receive resistance
in RoI from religious lobby groups, even if evidence
from health economic analysis in other contexts indi-
cates that this investment may lead to health gain for the
population.30
Limitations and strengths
There are a number of aspects of the methodology
where alternative approaches would have been desirable.
First, the data were entirely self-reported in the format
of a telephone interview. This is subject to the usual pro-
blems of recall and social desirability biases in measure-
ment. However, this is a widely used approach with
established reliability and validity that may be superior
to face-to-face interviews for sensitive topics.31 Second,
the cross-sectional study design does not allow any
causal inferences to be made from the data, as temporal-
ity in the relationships between variables cannot be
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established. Third, it would have been preferable to
have psychometrically validated measures of concerns
about the pill15 and other related psychological con-
structs related to medication beliefs14 and LARCs rather
than the single item measures used in this study that
only addressed the OCP. Fourth, there are a number of
additional measures that were not included that would
have provided useful information on contraceptive
choice; for example, whether the combined oral contra-
ceptive or the progesterone only pill was used and/or
whether the participant’s reason for using contraception
was for contraception only or for other medical reasons.
Finally, this is a unique healthcare context where
funding models for contraceptive services differ from
many other healthcare systems.
Nevertheless, there are several strengths to the present
study which help to mitigate these limitations, including
the representative sample of the general population within
the speciﬁed age band who provided anonymised data,
the reporting of multivariable and moderation analyses to
provide a more detailed and nuanced assessment of the
relationship between a broad range of predictors and pre-
scription contraceptive use, the separate analyses for two
different classes of LARCs which are sometimes consid-
ered together,16 and the use of relatively recently collected
data on this topic. This is particularly important due to the
changing nature of contraceptive use over the past 10–
15 years in this2 and other international contexts.1
CONCLUSION
Prescription contraceptive use is sociodemographically
patterned with LARCs methods in particular being asso-
ciated with lower incomes in RoI. Despite the estab-
lished safety of the OCP, concerns remain prevalent in
RoI, which may reﬂect the sociocultural context sur-
rounding contraception. These concerns are important
and modiﬁable determinants of contraceptive-related
behaviour that appear to have more resonance among
older users of contraception. The evidence from this
study suggests that further efforts are required to clarify
the health risks associated with the OCP and LARCs.
Future work will also need to establish who (eg, GP or
nurse), where (eg, primary care or educational settings)
and how (eg, during consultations or sex education
classes), this can be optimally delivered.
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